Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

Antoniou, A., Pharoah, P.D.P., Narod, S., Risch, H.A., Eyfjord, J.E., Hopper, J.L., Loman, N., Olsson, H. +25 more·2003·The American Journal of Human Genetics
DOI 10.1086/375033

Cited by (1,009)

Items 701–800 of 1,009

  1. Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers
    Susan L. Neuhausen, Sean S. Brummel, Yuan Chun Ding, Christian Fridolin Singer, Georg Pfeiler, Henry T. Lynch, Katherine L. Nathanson, Timothy Richard Rebbeck, Judy Ellen Garber, Fergus J. Couch et al. · 2009 · Breast Cancer Research
  2. Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)
    Pilar Blay, Íñigo Santamaría, Ana S. Pitiot, M. Luque, Marta G. Alvarado, Ana Lastra, Yolanda Fernández, Ángeles Paredes, José M.P. Freije, Milagros Balbı́n · 2013 · BMC Cancer
  3. Preserving the Self: The Process of Decision Making About Hereditary Breast Cancer and Ovarian Cancer Risk Reduction
    A. Fuchsia Howard, Lynda G. Balneaves, Joan L. Bottorff, Patricia Rodney · 2010 · Qualitative Health Research
  4. Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort
    Dejana Braithwaite, Diana L. Miglioretti, Weiwei Zhu, Joshua Demb, Amy Trentham‐Dietz, Brian L. Sprague, Jeffrey A. Tice, Tracy Onega, Louise M. Henderson, Diana S.M. Buist et al. · 2018 · JAMA Internal Medicine
  5. Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes in 2769 unselected breast cancer patients in China
    Mei Deng, Huihui Chen, Xuan Zhu, Meng Luo, Kun Zhang, Chunjing Xu, Kaimin Hu, Pu Cheng, Jiaojiao Zhou, Shu Sen Zheng et al. · 2019 · International Journal of Cancer
  6. Fertility preservation in patients with non-oncological conditions
    Yariv Gidoni, Hananel E. G. Holzer, Togas Tulandi, Seang Lin Tan · 2008 · Reproductive BioMedicine Online
  7. Breast MRI for Women With Hereditary Cancer Risk
    Mark E. Robson · 2004 · JAMA
  8. Classifying Variants of Undetermined Significance in BRCA2 with Protein Likelihood Ratios
    Rachel Karchin, Mukesh K. Agarwal, Andrej Šali, Fergus J. Couch, Mary Stanley Beattie · 2008 · Cancer Informatics
  9. Young adult daughters of BRCA1/2 positive mothers: What do they know about hereditary cancer and how much do they worry?
    Andrea Farkas Patenaude, Nadine Tung, Paula D. Ryan, Leif William Ellisen, Larissa Hewitt, Katherine A. Schneider, Kenneth P. Tercyak, Julie Aldridge, Judy Ellen Garber · 2013 · Psycho-Oncology
  10. BRCA1 and BRCA2 Germline Mutations in Malaysian Women with Early-Onset Breast Cancer without a Family History
    Gaik Theng Toh, Peter Choon Eng Kang, Sharlene S. W. Lee, Daphne Shin‐Chi Lee, Sheau Yee Lee, Suhaida A. Selamat, Nur Aishah Mohd Taib, Sook‐Yee Yoon, Cheng Har Yip, Soo‐Hwang Teo · 2008 · PLoS ONE
  11. Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women
    Sarah Charles, Lisa Jay Kessler, Jill E. Stopfer, Susan M. Domchek, Chanita Hughes Halbert · 2006 · Patient Education and Counseling
  12. Communicating BRCA1/2 genetic test results within the family: A qualitative analysis
    Caroline Dancyger, Mel Wiseman, Chris Jacobs, Jonathan Ashley Smith, Melissa Wallace, Susan Michie · 2011 · Psychology and Health
  13. Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical Laboratory
    Charles M. Strom, Steven P. Rivera, Christopher D. Elzinga, Taraneh E Angeloni, Sun Hee Rosenthal, Dana M. Goos, Martin F.E. Siaw, Jamie L. Platt, Cory Braastadt, Linda L. Cheng et al. · 2015 · PLoS ONE
  14. Systemic therapy options in BRCA mutation-associated breast cancer
    Soley Bayraktar, Stefan Glück · 2012 · Breast Cancer Research and Treatment
  15. Application of Screening Principles to the Reconstructed Breast
    Jennifer Zakhireh, Barbara L Fowble, Laura J. Esserman · 2009 · Journal of Clinical Oncology
  16. Reproductive factors and breast cancer risk among BRCA1 or BRCA2 mutation carriers: Results from ten studies
    Hong Pan, Zhongyuan He, Lijun Ling, Qiang Ding, Lin Chen, Xiaoming Zha, Wenbin Zhou, Xiaoan Liu, Shui Wang · 2013 · Cancer Epidemiology
  17. Sexual activity and functioning after risk-reducing salpingo-oophorectomy: Impact of hormone replacement therapy
    Nora Johansen, Astrid Helene Liavaag, Tom Tanbo, Alv Andreas Dahl, Are Hugo Pripp, Trond Melbye Michelsen · 2015 · Gynecologic Oncology
  18. Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review
    Diana Eccles, Judith Balmañà, Joe Clune, BIRGIT EHLKEN, Annegret Gohlke, Ceri Hirst, Danielle M. Potter, Claudia Schroeder, Jerzy Edward Tyczynski, Encarna B. Gómez-García · 2016 · Advances in Therapy
  19. Detection of Germline Mutation in Hereditary Breast and/or Ovarian Cancers by Next-Generation Sequencing on a Four-Gene Panel
    Ava Kwong, Vivian Yvonne Shin, Chun Hang Au, F. B. F. Law, Dona N.Y. Ho, Bui Kar Ip, Anthony T. C. Wong, Silvia Lau, Rene M.Y. To, Gigi Choy et al. · 2016 · Journal of Molecular Diagnostics
  20. Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations
    Lilian Jara S, Sebastián Morales, Tomas de Mayo, Patricio González‐Hormazábal, Valentina Carrasco, Raúl Godoy · 2017 · Biological Research
  21. Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance
    Christoph Engel, Christine Fischer, Silke Zachariae, Karolin Bucksch, Kerstin Rhiem, Jutta Giesecke, N Herold, Barbara Wappenschmidt, VF Hübbel, Monika Maringa et al. · 2019 · International Journal of Cancer
  22. Guidelines for Genetic Risk Assessment of Hereditary Breast and Ovarian Cancer: Early Disagreements and Low Utilization
    Douglas E. Levy, Judy Ellen Garber, Alexandra E. Shields · 2009 · Journal of General Internal Medicine
  23. Fertility Intentions Following Testing for a BRCA1 Gene Mutation
    Ken Robert Smith, Lee Ellington, Anna Chan, Robert T. Croyle, Jeffrey R. Botkin · 2004 · Cancer Epidemiology Biomarkers & Prevention
  24. Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers
    Daniel R. Barnes, Antonis C. Antoniou · 2012 · Journal of Internal Medicine
  25. DNA Repair Mechanisms, Protein Interactions and Therapeutic Targeting of the MRN Complex
    Claire E. McCarthy, Fatima Darwiche, Michael A. Tainsky · 2022 · Cancers
  26. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks
    Anna Jakubowska, Jacek Gronwald, Janusz Menkiszak, Bohdan Górski, Tomasz Huzarski, Tomasz Byrski, Lutz Edler, Jan Lubiński, Rodney John Scott, Ute Hamann · 2006 · Breast Cancer Research and Treatment
  27. Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer
    Korean Breast Cancer Study Group, Haeyoung Kim, Dae-Yeon Cho, Doo Ho Choi, Suyoun Choi, Inkyung Shin, Won Park, Seung Jae Huh, Sung Hee Han, Min Hyuk Lee et al. · 2012 · Breast Cancer Research and Treatment
  28. Identification and Management of Women at High Risk for Hereditary Breast/Ovarian Cancer Syndrome
    Elissa M. Ozanne, Andrea Loberg, Sherwood S. Hughes, Christine Lawrence, Brian Drohan, Alan Semine, Michael S. Jellinek, Claire Cronin, Frederick Heaton Millham, Dana Dowd et al. · 2009 · The Breast Journal
  29. BRCA in breast cancer: ESMO Clinical Recommendations
    Judith Balmañà, Orland Dı́ez, M. Castiglione · 2009 · Annals of Oncology
  30. Differences in BRCA counseling and testing practices based on ordering provider type
    Deborah L. Cragun, Lucia P. Camperlengo, Emily K. Robinson, Meghan Caldwell, Jongphil Kim, Catherine Phelan, Álvaro N.A. Monteiro, Susan Thomas Vadaparampil, Thomas A. Sellers, Tuya Pal · 2014 · Genetics in Medicine
  31. Ovarian Pathology in Risk-reducing Salpingo-oophorectomies From Women With BRCA Mutations, Emphasizing the Differential Diagnosis of Occult Primary and Metastatic Carcinoma
    Joseph T. Rabban, Michael Barnes, Lee-may Chen, C. Bethan Powell, Beth Crawford, Charles J. Zaloudek · 2009 · The American Journal of Surgical Pathology
  32. Transitional Cell Metaplasia of Fallopian Tube Fimbriae
    Joseph T. Rabban, Beth Crawford, Lee-may Chen, C. Bethan Powell, Charles J. Zaloudek · 2008 · The American Journal of Surgical Pathology
  33. The role of BRCA1 in homologous recombination repair in response to replication stress: significance in tumorigenesis and cancer therapy
    Junran Zhang · 2013 · Cell & Bioscience
  34. Breast Cancer Following Ovarian Cancer inBRCAMutation Carriers
    Alexandra Gangi, Ilana A. Cass, Daniel Y. Paik, Galinos Barmparas, Beth Y. Karlan, Catherine Dang, Andrew John Li, Christine Walsh, B.J. Rimel, Farin F. Amersi · 2014 · JAMA Surgery
  35. Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond
    Michael J. Hall, Elias I. Obeid, Sharon Schwartz, Gina M. Mantia-Smaldone, Andrea D. Forman, Mary Beryl Daly · 2016 · Gynecologic Oncology
  36. Increased risk of brain metastases in ovarian cancer patients with BRCA mutations
    Elena Ratner, MEHMET MURAT BALA, Melinda Louie-Gao, Ebru Aydin, Sebastien J. Hazard, Priscilla Kaliopi Brastianos · 2019 · Gynecologic Oncology
  37. Prophylactic salpingo‐oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation
    Fatima Laki, Youlia Kirova, Pascale This, for the IC‐BOCRSG, C PLANCHER, Bernard Jean Roger Asselain, Xavier Sastre‐Garau, Dominique Stoppa‐Lyonnet, Remy Jacques Salmon · 2007 · Cancer
  38. Clinical Considerations ofBRCA1- andBRCA2-Mutation Carriers: A Review
    Olga Bougie, Johanne Ingrid Weberpals · 2011 · International Journal of Surgical Oncology
  39. Frozen Section Diagnosis of Ovarian Epithelial Tumors: Diagnostic Pearls and Pitfalls
    Natália Buza · 2018 · Archives of Pathology & Laboratory Medicine
  40. Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship
    Prarthna V Bhardwaj, Shilpi Gupta, Alexa Elyash, Eleonora Teplinsky · 2024 · Current Oncology Reports
  41. Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells
    Elizabeth Alli, Vandana B. Sharma, Anne‐Renee Hartman, Patrick S. Lin, Lisa A. McPherson, James M. Ford · 2011 · BMC Pharmacology
  42. Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Joanne Kotsopoulos, Jan Lubiński, Henry T. Lynch, Jan G.M. Klijn, Parviz Ghadirian, Susan L. Neuhausen, Charmaine Kim‐Sing, William David Foulkes, Pål Møller, Claudine J. Isaacs et al. · 2007 · Breast Cancer Research and Treatment
  43. Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Joanne Kotsopoulos, Jan Lubiński, Susan L. Neuhausen, Henry T. Lynch, Barry P. Rosen, Peter Ainsworth, Pål Møller, Parviz Ghadirian, Claudine J. Isaacs, Beth Y. Karlan et al. · 2005 · Gynecologic Oncology
  44. The role of body size and physical activity on the risk of breast cancer in BRCA mutation carriers
    Rachael Pettapiece-Phillips, Steven Alexander Narod, Joanne Kotsopoulos · 2015 · Cancer Causes & Control
  45. Results of an Intervention for Individuals and Families with BRCA Mutations: A Model for Providing Medical Updates and Psychosocial Support Following Genetic Testing
    Wendy C. McKinnon, Shelly J. Naud, Taka Ashikaga, Rose Colletti, Marie E. Wood · 2007 · Journal of Genetic Counseling
  46. Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers
    Reka E. Pataky, Linlea Armstrong, Stephen Chia, Andrew J. Coldman, Charmaine Kim‐Sing, Barbara C. McGillivray, Jenna Scott, Christine Wilson, Stuart J Peacock · 2013 · BMC Cancer
  47. Do BRCA1 and BRCA2 Mutation Carriers Have Earlier Natural Menopause Than Their Noncarrier Relatives? Results From the Kathleen Cuningham Foundation Consortium for Research Into Familial Breast Cancer
    Ian M Collins, Roger Laughlin Milne, Sue Anne McLachlan, Michael Leonard Friedlander, Martha Hickey, Prue C. Weideman, Kate Birch, John Llewelyn Hopper, Kelly‐Anne Phillips · 2013 · Journal of Clinical Oncology
  48. NCCN Clinical Practice Guidelines in Oncology for Breast Cancer Risk Reduction
    Elizabeth Pritchard, Victoria L. Seewaldt, Rena V. Sellin, Charles L. Shapiro, John Headley Ward, Therese Bartholomew Bevers, Deborah Kay Armstrong, Banu Arun, Robert W. Carlson, Kenneth H. Cowan et al. · 2010
  49. Unexpected CDH1 Mutations Identified on Multigene Panels Pose Clinical Management Challenges
    Katrina J. Lowstuter, Carin R. Espenschied, Duveen Sturgeon, Charite Nicolette Ricker, Rachid Karam, Holly LaDuca, Julie O. Culver, Jill S. Dolinsky, Elizabeth Chao, Julia Sturgeon et al. · 2017 · JCO Precision Oncology
  50. Family Communication, Risk Perception and Cancer Knowledge of Young Adults from BRCA1/2 Families: a Systematic Review
    Alison Luk Young, Phyllis Noemi Butow, Janine Vetsch, Veronica Frances Quinn, Andrea Farkas Patenaude, Kathy Tucker, Claire Elizabeth Wakefield · 2017 · Journal of Genetic Counseling
  51. Risk Reduction and Survival Benefit of Risk-Reducing Salpingo-oophorectomy in Hereditary Breast Cancer: Meta-analysis and Systematic Review
    Yelei Xiao, Kang Wang, Qiang Liu, Jie Li, Xiang Zhang, Hongyuan Li · 2018 · Clinical Breast Cancer
  52. Multi gene panel testing for hereditary breast cancer - is it ready to be used?
    Andreea M. Catana, Adina Patricia Apostu, Răzvan-Geo Antemie · 2019 · Medicine and Pharmacy Reports
  53. Homologous recombination deficiency in breast cancer: Implications for risk, cancer development, and therapy
    Rayhaan Ali, Stuart McIntosh, Kienan I. Savage · 2020 · Genes Chromosomes and Cancer
  54. Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes—Practice resource of the National Society of Genetic Counselors
    Janice L. Berliner, Shelly Ann Cummings, Brittany Boldt Burnett, Charite Nicolette Ricker · 2021 · Journal of Genetic Counseling
  55. Family history: Still relevant in the genomics era
    Megan J. Doerr, Kathryn Teng · 2012 · Cleveland Clinic Journal of Medicine
  56. BRCA mutation‐negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA‐negative experience
    Alexis D. Bakos, Sadie Pauline Hutson, Jennifer T. Loud, June A. Peters, Ruthann M. Giusti, Mark H. Greene · 2008 · Health Expectations
  57. Animal Studies of Charged Particle-induced Carcinogenesis
    Helle Bielefeldt‐Ohmann, Paula C. Genik, Christina M. Fallgren, Robert L. Ullrich, Michael M. Weil · 2012 · Health Physics
  58. Mechanisms of inherited cancer susceptibility
    Shirley Victoria Hodgson · 2008 · Journal of Zhejiang University SCIENCE B
  59. Risk of having BRCA1 mutation in high‐risk women with triple‐negative breast cancer: a meta‐analysis
    N. M. Tun, Gina M. Villani, Kai‐Ren Ong, Linus Yoe, ZM Bo · 2013 · Clinical Genetics
  60. The genetic prediction of risk for gynecologic cancers
    Leslie M. Randall, Bhavana Pothuri · 2016 · Gynecologic Oncology
  61. A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer
    Yonghong Li, André R. Arellano, Lance A. Bare, Richard A. Bender, Charles M. Strom, James J. Devlin · 2017 · Value in Health
  62. Current state and controversies in fertility preservation in women with breast cancer
    Enes Taylan, Kutluk Oktay · 2017 · World Journal of Clinical Oncology
  63. Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO)
    GENEPSO, Julie Lecarpentier, Catherine Noguès, Emmanuelle Mouret‐Fourme, Dominique Stoppa‐Lyonnet, Christine Lasset, Olivier Caron, Jean‐Pierre Fricker, Laurence Gladieff, Laurence Olivier Faivre et al. · 2011 · Breast Cancer Research and Treatment
  64. Breast Cancer Risks for BRCA1/2 Carriers
    Douglas F. Easton, John Llewelyn Hopper, Duncan C. Thomas, Antonis C. Antoniou, Paul D.P. Pharoah, Alice S. Whittemore, Robert W. Haile · 2004 · Science
  65. Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers
    Susan J. Ramus, Christiana Kartsonaki, Simon A. Gayther, Paul D.P. Pharoah, Olga M. Sinilnikova, Jonathan Beesley, X. Chen, L. McGuffog, Sue C. Healey, Fergus J. Couch et al. · 2010 · JNCI Journal of the National Cancer Institute
  66. Spontaneous and therapeutic abortions and the risk of breast cancer among BRCAmutation carriers
    Eitan Friedman, Joanne Kotsopoulos, Jan Lubiński, Henry T. Lynch, Parviz Ghadirian, Susan L. Neuhausen, Claudine J. Isaacs, Barbara Weber, William David Foulkes, Pål Møller et al. · 2006 · Breast Cancer Research
  67. Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2
    Susan M. Domchek, Mia M. Gaudet, Jill E. Stopfer, M. H. Fleischaut, Jacquelyn M. Powers, Noah D. Kauff, Kenneth Offit, Katherine L. Nathanson, Mark E. Robson · 2009 · Breast Cancer Research and Treatment
  68. Awareness and Preferences Regarding BRCA1/2 Genetic Counseling and Testing Among Latinas and Non‐Latina White Women at Increased Risk for Hereditary Breast and Ovarian Cancer
    Amanda Gammon, Erin Rothwell, Rebecca G. Simmons, Jan T. Lowery, Lori Ballinger, Deirdre A. Hill, Kenneth M. Boucher, Anita Yeomans Kinney · 2011 · Journal of Genetic Counseling
  69. Identification of fifteen novel germline variants in theBRCA13′UTR reveals a variant in a breast cancer case that introduces a functionalmiR-103target site
    Brooke L. Brewster, Francesca Rossiello, Juliet D. French, Stacey L. Edwards, Ee Ming Wong, Ania Wronski, Phillip J Whiley, Nicola Waddell, Xiaowei Chen, Betsy A. Bove et al. · 2012 · Human Mutation
  70. Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival
    Joyce F. Liu, Mihaela C. Cristea, Paul Henry Frankel, Susan L. Neuhausen, Linda Steele, Verena Engelstaedter, Ursula A. Matulonis, Sharon R. Sand, Nadine Tung, Judy Ellen Garber et al. · 2012 · Cancer Genetics
  71. BRCA1 p.Val1688del Is a Deleterious Mutation That Recurs in Breast and Ovarian Cancer Families From Northeast Italy
    Sandro Malacrida, Simona Agata, Monia Callegaro, Cinzia Casella, Daniela Barana, Maria Chiara Scaini, Siranoush Manoukian, Cristina Oliani, Paolo Radice, Monica Barile et al. · 2007 · Journal of Clinical Oncology
  72. Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families
    Katri Pylkäs, Hannele Erkko, Jenni Nikkilä, Szilvia Sólyom, Robert Winqvist · 2008 · BMC Cancer
  73. Preventing breast and ovarian cancers in high‐risk BRCA1 and BRCA2 mutation carriers
    Ian M Collins, Roger Laughlin Milne, Prue C. Weideman, Sue‐Anne McLachlan, Michael Leonard Friedlander, John Llewelyn Hopper, Kelly‐Anne Phillips · 2013 · The Medical Journal of Australia
  74. BRCAMutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations
    Mai A. Elezaby, Brittany F. Lees, Katherine E. Maturen, Lisa Marie Barroilhet, Kari Braun Wisinski, Sarina Schrager, Lee Gravatt Wilke, Elizabeth A. Sadowski · 2019 · Radiology
  75. Association of Single Nucleotide Polymorphisms in Glycosylation Genes with Risk of Epithelial Ovarian Cancer
    Thomas A. Sellers, Yifan Huang, Julie M. Cunningham, Ellen L. Goode, Rebecca Sutphen, Robert Alan Vierkant, Linda E. Kelemen, Zachary S. Fredericksen, Mark Liebow, V. Shane Pankratz et al. · 2008 · Cancer Epidemiology Biomarkers & Prevention
  76. Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk
    Charlotte Hsieh Ahern, Ya‐Chen Tina Shih, Wenli Dong, Giovanni Parmigiani, Yu Shen · 2014 · British Journal of Cancer
  77. Predictors of breast cancer screening behavior in women with a strong family history of the disease
    Melanie Anne Price, Phyllis Noemi Butow, Margaret A. Charles, Tracey Bullen, Bettina Meiser, Joanne M. McKinley, Sue‐Anne McLachlan, Kelly‐Anne Phillips · 2010 · Breast Cancer Research and Treatment
  78. Management of sexual problems in cancer patients and survivors
    Veronica Sanchez Varela, Eric S. Zhou, Sharon L. Bober · 2013 · Current Problems in Cancer
  79. Oligogenic combinations associated with breast cancer risk in women under 53�years of age
    Christopher E. Aston, David A. Ralph, Dominique Lalo, Sharmila Manjeshwar, Bobby A. Gramling, Daniele C. DeFreese, Amy D. West, Dannielle E. Branam, Linda F. Thompson, Melissa Craft et al. · 2004 · Human Genetics
  80. BRCA1 Regulates IFN-γ Signaling through a Mechanism Involving the Type I IFNs
    Niamh E. Buckley, Alison M. Hosey, Julia J. Gorski, James W. Purcell, Jude M. Mulligan, Denis Paul Harkin, Paul B. Mullan · 2007 · Molecular Cancer Research
  81. Hereditary gynaecological malignancies: advances in screening and treatment
    Ann Katherine Folkins, Teri A. Longacre · 2012 · Histopathology
  82. Epigenetics and the Social Work Imperative
    Terri D. Combs-Orme · 2012 · Social Work
  83. Ovarian cancer: Status of homologous recombination pathway as a predictor of drug response
    Nicolas De Picciotto, Wulfran Cacheux, Arnaud D. Roth, Pierre Olivier Chappuis, Sana Intidhar Labidi‐Galy · 2016 · Critical Reviews in Oncology/Hematology
  84. Why Are There So Many Mastectomies in the United States?
    Anita Mamtani, Monica Morrow · 2016 · Annual Review of Medicine
  85. Developmental Exposure to Endocrine Disrupting Chemicals Alters the Epigenome: Identification of Reprogrammed Targets
    Lauren Prusinski, Ayman A. Al-Hendy, Qiwei Yang · 2016 · Gynecology and Obstetrics Research - Open Journal
  86. Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act
    Roi Tschernichovsky, Annekathryn Goodman · 2017 · The Oncologist
  87. Morphological predictors of BRCA1 germline mutations in young women with breast cancer
    Melissa C. Southey, Susan J. Ramus, James G. Dowty, Letitia D. Smith, Andrea A. Tesoriero, Ee Ming Wong, Gillian S. Dite, Mark A. Jenkins, Graham B Byrnes, Ingrid Winship et al. · 2011 · British Journal of Cancer
  88. Contribution of BRCA1 and BRCA2 germ‐line mutations to the incidence of breast cancer in young women: Results from a prospective population‐based study in France
    Valérie Bonadona, Olga M. Sinilnikova, Sandrine Chopin, Antonis C. Antoniou, Hervé Mignotte, Patrice Mathevet, Alain G Bremond, Alain Martin, Jean-Yves Bobin, Pascale Romestaing et al. · 2005 · Genes Chromosomes and Cancer
  89. Augmentation of the antitumor effects of PARP inhibitors in triple-negative breast cancer via degradation by hydrophobic tagging modulation
    Ahra Go, Jeong Woon Jang, Woori Lee, Jae Du Ha, Hyun Jin Kim, Hye Jin Nam · 2020 · European Journal of Medicinal Chemistry
  90. Artificial Intelligence in Breast Cancer Diagnosis and Treatment: Advances in Imaging, Pathology, and Personalized Care
    Petar Angelov Uchikov, Usman Khalid, Granit Harris Dedaj-Salad, Dibya Ghale, Harney Rajadurai, Maria Ilieva Kraeva, Krasimir Iliev Kraev, Bozhidar Krasimirov Hristov, Mladen Doykov, Vanya Mitova et al. · 2024 · Life
  91. Toward Classification of BRCA1 Missense Variants Using a Biophysical Approach
    Pamela J. E. Rowling, Rebecca S. Cook, Laura S. Itzhaki · 2010 · Journal of Biological Chemistry
  92. Inherited and acquired alterations in development of breast cancer
    Laura Ottini, Piera Rizzolo, Valentina Silvestri, Mario Falchetti · 2011 · The Application of Clinical Genetics
  93. Telephone Genetic Counseling for High-Risk Women Undergoing BRCA1 and BRCA2 Testing: Rationale and Development of a Randomized Controlled Trial
    Beth N. Peshkin, Tiffani A. DeMarco, Kristi D. Graves, Karen Brown, Rachel H. Nusbaum, Diana Moglia, Andrea D. Forman, Heiddis Bjork Valdimarsdottir, Marc D. Schwartz · 2008 · Genetic Testing
  94. Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment
    Allison W. Kurian, Kerry E. Kingham, James M. Ford · 2014 · Current Opinion in Obstetrics & Gynecology
  95. BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls
    Ang Li, Rong Xie, Qihuan Zhi, Yixiao Deng, Yangming Wu, Weiwei Li, Lu Yang, Zinan Jiao, Jia‐Qi Luo, Yi Zi et al. · 2018 · Gynecologic Oncology
  96. Hereditary Breast and Ovarian Cancer Syndrome
    Mayuko Inuzuka, Seigo Nakamura · 2009 · Gynecologic Oncology
  97. CSMD3 is Associated with Tumor Mutation Burden and Immune Infiltration in Ovarian Cancer Patients
    Nan Lü, Jinhui Liu, Mengting Xu, Jianqiang Liang, Yichun Wang, Zhipeng Wu, Yan Tian Xing, Feiyang Diao · 2021 · International Journal of General Medicine
  98. Management of women at high risk for breast cancer: New imaging beyond mammography
    Christiane Katharina Kuhl, Walther Christian Kuhn, Hans Heinz Schild · 2005 · The Breast
  99. Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK
    Anne Elizabeth Cust, Mark Harland, Enes Makalic, Daniel Francis Schmidt, James G. Dowty, Joanne F. Aitken, Chantelle Agha‐Hamilton, Bruce Konrad Armstrong, Jenny H Barrett, May Chan et al. · 2011 · Journal of Medical Genetics
  100. BRCA Mutation Frequency and Penetrance: New Data, Old Debate
    Kenneth Offit · 2006 · JNCI Journal of the National Cancer Institute